Tetsuya Abe

474 total citations
31 papers, 371 citations indexed

About

Tetsuya Abe is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Tetsuya Abe has authored 31 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Physiology, 8 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in Tetsuya Abe's work include Pain Mechanisms and Treatments (7 papers), Neuropeptides and Animal Physiology (5 papers) and Lung Cancer Treatments and Mutations (5 papers). Tetsuya Abe is often cited by papers focused on Pain Mechanisms and Treatments (7 papers), Neuropeptides and Animal Physiology (5 papers) and Lung Cancer Treatments and Mutations (5 papers). Tetsuya Abe collaborates with scholars based in Japan, United States and China. Tetsuya Abe's co-authors include Hiroki Kawamura, Hisami Watanabe, Toru Abo, M. Matsushita, Tomohiko Sasase, Shinichi Sugiyo, Masahiro Urade, Masayuki Kobayashi, Fumitake Gejyo and Masami Shinohara and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Neuroscience.

In The Last Decade

Tetsuya Abe

30 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tetsuya Abe Japan 13 108 107 70 66 65 31 371
Nyanbol Kuol Australia 9 199 1.8× 132 1.2× 64 0.9× 101 1.5× 27 0.4× 13 482
Emily Wilson United States 8 48 0.4× 293 2.7× 81 1.2× 98 1.5× 88 1.4× 13 565
Regine Potthast Germany 9 42 0.4× 287 2.7× 80 1.1× 40 0.6× 66 1.0× 9 517
Émilie Degagné Canada 9 55 0.5× 253 2.4× 29 0.4× 99 1.5× 59 0.9× 9 495
Samir Makani United States 9 71 0.7× 97 0.9× 113 1.6× 83 1.3× 106 1.6× 24 546
Camila Araujo United States 11 42 0.4× 211 2.0× 38 0.5× 98 1.5× 35 0.5× 14 525
L. Laurén Finland 15 250 2.3× 180 1.7× 30 0.4× 41 0.6× 25 0.4× 26 451
Amanda A. Hill United States 9 83 0.8× 226 2.1× 37 0.5× 220 3.3× 99 1.5× 17 638
Takeshi Kiyoi Japan 13 36 0.3× 165 1.5× 41 0.6× 78 1.2× 40 0.6× 38 363

Countries citing papers authored by Tetsuya Abe

Since Specialization
Citations

This map shows the geographic impact of Tetsuya Abe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tetsuya Abe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tetsuya Abe more than expected).

Fields of papers citing papers by Tetsuya Abe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tetsuya Abe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tetsuya Abe. The network helps show where Tetsuya Abe may publish in the future.

Co-authorship network of co-authors of Tetsuya Abe

This figure shows the co-authorship network connecting the top 25 collaborators of Tetsuya Abe. A scholar is included among the top collaborators of Tetsuya Abe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tetsuya Abe. Tetsuya Abe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ito, Kentaro, Masahiro Morise, Kazushige Wakuda, et al.. (2021). A multicenter cohort study of osimertinib compared with afatinib as first-line treatment for EGFR-mutated non-small-cell lung cancer from practical dataset: CJLSG1903. ESMO Open. 6(3). 100115–100115. 33 indexed citations
2.
Miura, Satoru, Satoshi Watanabe, Hiroshi Tanaka, et al.. (2021). A prospective phase II study of multimodal prophylactic treatment for afatinib-induced adverse events in advanced non-small cell lung cancer (Niigata Lung Cancer Treatment Group 1401). Translational Lung Cancer Research. 10(1). 252–260. 6 indexed citations
3.
Watanabe, Satoshi, Naoya Matsumoto, Jun Koshio, et al.. (2019). MA21.05 Phase II Trial of the Combination of Alectinib with Bevacizumab in ALK-Positive Nonsquamous Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 14(10). S336–S336. 4 indexed citations
4.
Kondo, Rie, Satoshi Watanabe, Satoshi Shoji, et al.. (2018). A Phase II Study of Irinotecan for Patients with Previously Treated Small-Cell Lung Cancer. Oncology. 94(4). 223–232. 38 indexed citations
5.
Takaoka, Kazuki, Tetsuya Abe, Masami Shinohara, et al.. (2015). Establishment of an Animal Model of Bisphosphonate-Related Osteonecrosis of the Jaws in Spontaneously Diabetic Torii Rats. PLoS ONE. 10(12). e0144355–e0144355. 15 indexed citations
6.
7.
8.
Omachi, Naoki, Motohiro Tamiya, Akihiro Tamiya, et al.. (2014). Preliminary analysis of the phase II study of pemetrexed plus carboplatin as first-line chemotherapy for elderly patients with advanced nonsquamous, non-small cell lung cancer.. Journal of Clinical Oncology. 32(15_suppl). e19162–e19162. 1 indexed citations
9.
Abe, Tetsuya, et al.. (2013). c-Fos induction in the brainstem following electrical stimulation of the trigeminal ganglion of chronically mandibular nerve-transected rats. Somatosensory & Motor Research. 30(4). 175–184. 3 indexed citations
10.
Honda, Kosuke, et al.. (2011). Causes of Persistent Joint Pain After Arthrocentesis of Temporomandibular Joint. Journal of Oral and Maxillofacial Surgery. 69(9). 2311–2315. 12 indexed citations
11.
Hasegawa, Makoto, et al.. (2009). Theophylline attenuates hippocampal blood flow responses induced by tooth pulp stimulation in rats. Neuroscience Research. 65(2). 156–159. 5 indexed citations
12.
Sasase, Tomohiko, Tetsuya Abe, Takeshi Ohta, et al.. (2009). Protein kinase C beta inhibitor prevents diabetic peripheral neuropathy, but not histopathological abnormalities of retina in Spontaneously Diabetic Torii rat. Diabetes Obesity and Metabolism. 11(11). 1084–1087. 26 indexed citations
13.
Honda, Kosuke, Naoto Kinoshita, Tetsuya Abe, Makoto Hasegawa, & Akihiko Shimizu. (2008). Efficacy of a new jet nozzle for removal of carious dentin with an air abrasion system. Dental Materials Journal. 27(6). 835–841. 4 indexed citations
14.
KAWAHARA, Takeo, Yoshito Okada, Satomi Saeki, et al.. (2007). A Case of Primary Squamous Cell Carcinoma in Gastric Remnant. The Japanese Journal of Gastroenterological Surgery. 40(10). 1666–1672. 3 indexed citations
15.
Sasase, Tomohiko, Hideki Yamada, Kenji Sakoda, et al.. (2004). Novel protein kinase C‐β isoform selective inhibitor JTT‐010 ameliorates both hyper‐ and hypoalgesia in streptozotocin‐ induced diabetic rats. Diabetes Obesity and Metabolism. 7(5). 586–594. 35 indexed citations
16.
Halder, Ramesh, Tetsuya Abe, Sufi Morshed, et al.. (2003). Onset of hepatic erythropoiesis after malarial infection in mice. Parasitology International. 52(4). 259–268. 17 indexed citations
17.
Abe, Tetsuya, et al.. (2002). Liver injury due to sequential activation of natural killer cells and natural killer T cells by carrageenan. Journal of Hepatology. 36(5). 614–623. 26 indexed citations
18.
Bannai, Makoto, Toshihiko Kawamura, Tetsuya Naito, et al.. (2001). Abundance of unconventional CD8+ natural killer T cells in the large intestine. European Journal of Immunology. 31(11). 3361–3369. 41 indexed citations
19.
Ohmura, Etsuji, Tetsuya Abe, & Hiroshi Eda. (1993). Ultrahigh-Speed Grinding. (1st Report). Computer Simulation on Surface Generation in Ultrahigh-Speed Grinding Process.. Journal of the Japan Society for Precision Engineering. 59(8). 1245–1250.
20.
Abe, Tetsuya, Hideyasu Hirano, Takahiko Katoh, et al.. (1992). Comparison of Ki-ras gene mutation among simultaneously occurring multiple urethan-induced lung tumors in individual mice. Carcinogenesis. 13(5). 851–855. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nyanbol Kuol Breakdown of academic impact, for papers by Emily Wilson Breakdown of academic impact, for papers by Regine Potthast Breakdown of academic impact, for papers by Émilie Degagné Breakdown of academic impact, for papers by Samir Makani Breakdown of academic impact, for papers by Camila Araujo Breakdown of academic impact, for papers by L. Laurén Breakdown of academic impact, for papers by Amanda A. Hill Breakdown of academic impact, for papers by Takeshi Kiyoi
Rankless by CCL
2026